80 + studies prove natural immunity is better and safer than the vaccines





Need for COVID-19 vaccine in previously infected individuals https://www.medrxiv.org/content/10.1101/2021.06.01.21258176v2

SARS-CoV-2-specific T-cell immunity in COVID-19 and SARS cases and uninfected controls https://www.nature.com/articles/s41586-020-2550-z

Comparison of natural SARS-CoV-2 immunity with vaccine-induced immunity: reinfections versus breakthrough infections https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1.full

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection https://rupress.org/jem/article/218/5/e20202617/211835/Highly-functional-virus-specific-cellular-immune

Large-scale study of antibody titer decline after BNT162b2 mRNA vaccine or SARS-CoV-2 infection https://www.medrxiv.org/content/10.1101/2021.08.19.21262111v1.full

Risk of SARS-CoV-2 reinfection in Austria https://onlinelibrary.wiley.com/doi/full/10.1111/eci.13520

SARS-CoV-2 specific T cells induced by mRNA vaccine recognize B.1.1.7 and B.1.351 variants but differ in longevity and homing properties depending on previous infection status https://www.biorxiv.org/content/10.1101/2021.05.12.443888v1

Good news: mild COVID-19 induces long-lasting antibody protection https://medicine.wustl.edu/news/good-news-mild-covid-19-induces-lasting-antibody-protection/

Robust neutralizing antibodies against SARS-CoV-2 infection persist for months https://www.science.org/doi/10.1126/science.abd7728

Evolution of antibody immunity to SARS-CoV-2 https://www.biorxiv.org/content/10.1101/2020.11.03.367391v2

Persistence of neutralizing antibodies one year after SARS-CoV-2 infection in humans https://onlinelibrary.wiley.com/doi/10.1002/eji.202149535

Quantification of the risk of reinfection by SARS – CoV – 2 over time https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209951/pdf/RMV-9999-e2260.pdf

Natural immunity to covid is powerful. Legislators seem afraid to say so https://www.washingtonpost.com/outlook/2021/09/15/natural-immunity-vaccine-mandate/

SARS-CoV-2 elicits strong adaptive immune responses regardless of disease severity

https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00203-6/fulltext

protection from prior SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: a three-month national experience from Israel https://www.medrxiv.org/content/10.1101/2021.04.20.21255670v1

Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees https://www.medrxiv.org/content/10.1101/2021.07.03.21259976v2

Having SARS-CoV-2 once confers much greater immunity than a vaccine, but vaccination remains vital https://www.science.org/content/article/having-sars-cov-2-once-confers-much-greater-immunity-vaccine-vaccination-remains-vital

Humoral and cellular immunities sustained during one year of COVID-19 convalescents https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab884/6381561#.YWGhCytQ_Hc.twitter

SARS-CoV-2-specific functional immune memory persists after mild COVID-19 https://www.cell.com/cell/fulltext/S0092-8674(20)31565-8?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867420315658%3Fshowall%3Dtrue

Discrete immune response signature to SARS-CoV-2 mRNA vaccination against infection https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3838993

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans https://www.nature.com/articles/s41586-021-03647-4

SARS-CoV-2 infection rates of antibody-positive healthcare workers compared with antibody-negative healthcare workers in England: a large multicenter prospective cohort study (SIREN) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext

Peak pandemic SARS-CoV-2 infection and seroconversion rates in frontline healthcare workers in London https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31484-7/fulltext

Antibodies to SARS-CoV-2 are associated with protection against reinfection https://www.medrxiv.org/content/10.1101/2020.11.18.20234369v1

longitudinal analysis shows extensive and long-lasting immune memory after SARS-CoV-2 infection with persistent antibody responses and memory B and T cells https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00203-2#%20

Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity https://www.cell.com/cell/fulltext/S0092-8674(20)31235-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867420312356%3Fshowall%3Dtrue

Detection of SARS-CoV-2-specific humoral and cellular immunity in convalescent individuals by COVID-19 https://www.cell.com/immunity/fulltext/S1074-7613(20)30181-3?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS107476132020301813%3Fshowall%3Dtrue

Robust SARS-CoV-2-specific T-cell immunity maintained 6 months after primary infection https://www.biorxiv.org/content/10.1101/2020.11.01.362319v1

Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T-cell reactivity in COVID-19-exposed donors and vaccinees https://www.biorxiv.org/content/10.1101/2021.02.27.433180v1

A SARS-CoV-2 reinfection rate of 1 to 1000 in members of a large health care provider in Israel: a preliminary report https://www.medrxiv.org/content/10.1101/2021.03.06.21253051v1

previous SARS-CoV-2 infection is associated with protection against symptomatic reinfection https://www.journalofinfection.com/article/S0163-4453(20)30781-7/fulltext

mRNA vaccine-induced T cells respond identically to worrisome variants of SARS-CoV-2, but differ in longevity and homing properties depending on prior infection status https://www.biorxiv.org/content/10.1101/2021.05.12.443888v2

Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and non-COVID-19 individuals https://www.cell.com/cell/fulltext/S0092-8674(20)30610-3

NIH Director’s Blog: Immune T cells may offer durable protection against COVID-19 https://directorsblog.nih.gov/2020/07/28/immune-t-cells-may-offer-lasting-protection-against-covid-19/

Ultrapotent antibodies against diverse and highly transmissible variants of SARS-CoV-2 https://www.science.org/doi/full/10.1126/science.abh1766

Why COVID-19 vaccines should not be necessary for all Americans https://www.usnews.com/news/national-news/why-covid-19-vaccines-should-not-be-required-for-all-americans

Prolonged but coordinated differentiation of long-lived SARS-CoV-2-specific CD8+ CD8+ T cells during COVID-19 convalescence https://www.biorxiv.org/content/10.1101/2021.04.28.441880v1

Decreased measles virus-specific CD4 T cell memory in subjects https://academic.oup.com/jid/article/190/8/1387/878306

Remembrance of things past: long-term B cell memory after infection and vaccination https://www.frontiersin.org/articles/10.3389/fimmu.2019.01787/full)

SARS-CoV-2-specific memory B cells from individuals with disease of varying severity recognize worrisome variants of SARS-CoV-2 https://www.medrxiv.org/content/10.1101/2021.05.28.21258025v1.full

Exposure to SARS-CoV-2 generates memory T cells in the absence of detectable viral infection https://www.nature.com/articles/s41467-021-22036-zCD8+

T cell responses in convalescent individuals with COVID-19 targeted to conserved epitopes of multiple prominent circulating variants of SARS-CoV-2 https://academic.oup.com/ofid/article/8/7/ofab143/6189113

https://journals.asm.org/doi/10.1128/jvi.02002-20?permanently=true

Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2 https://www.lji.org/news-events/news/post/exposure-to-common-cold-coronaviruses-can-teach-the-immune-system-to-recognize-sars-cov-2/)

Selective and cross-reactive SARS-CoV-2 T-cell epitopes in unexposed humans https://www.science.org/doi/10.1126/science.abd3871Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection https://www.sciencedirect.com/science/article/pii/S1521661621001510 Circulating and humoral follicular helper T cell responses in recovered patients with COVID-19 https://www.nature.com/articles/s41591-020-0995-0

Convergent antibody responses to SARS-CoV-2 in convalescent individuals https://www.nature.com/articles/s41586-020-2456-9 Rapid generation of durable B-cell memory for nucleocapsid proteins and SARS-CoV-2 spike in COVID-19 and convalescence https://www.science.org/doi/10.1126/sciimmunol.abf8891 Did you have COVID? You will probably produce antibodies for life https://www.nature.com/articles/d41586-021-01442-9 Most uninfected adults show pre-existing antibody reactivity to SARS-CoV-2 https://insight.jci.org/articles/view/146316

T cells reactive to SARS-CoV-2 in healthy donors and patients with COVID-19 https://www.nature.com/articles/s41586-020-2598-9

Naturally enhanced neutralizing amplitude against SARS-CoV-2 one year after infection https://www.nature.com/articles/s41586-021-03696-9 One year after mild COVID-19: most patients maintain specific immunity, but one in four still suffer long-term symptoms https://pubmed.ncbi.nlm.nih.gov/34362088/ IDSA https://www.idsociety.org/globalassets/idsa/media/clinician-call-slides–qa/07-17-21-clinician-call-slides-1.pdf

Assessment of protection against reinfection with SARS-CoV-2 among 4 million people tested for PCR in Denmark in 2020: a population-level observational study https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00575-4/fulltext

Individual cell profiles of T- and B-cell repertoires after SARS-CoV-2 mRNA vaccination https://www.biorxiv.org/content/10.1101/2021.07.14.452381v1

SARS-CoV-2 antibody positivity protects against reinfection for at least seven months with 95% efficacy https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00141-3/fulltext#%20Orthogonal

SARS-CoV-2 serological assays allow surveillance of low-prevalence communities and reveal durable humoral immunity https://www.cell.com/immunity/fulltext/S1074-7613(20)30445-3

Anti-peak antibody response to natural SARS-CoV-2 infection in general population https://www.medrxiv.org/content/10.1101/2021.07.02.21259897v1

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers https://www.nejm.org/doi/full/10.1056/NEJMoa2034545?s=09

researchers find long-lasting immunity to 1918 pandemic virus https://www.cidrap.umn.edu/news-perspective/2008/08/researchers-find-long-lived-immunity-1918-pandemic-virus

NATURE journal publication 2008 https://www.nature.com/articles/nature07231

Live virus neutralization testing in convalescent patients and subjects vaccinated against SARS-CoV-2 isolates 19A, 20B, 20I / 501Y.V1 and 20H / 501Y.V2 https://www.medrxiv.org/content/10.1101/2021.05.11.21256578v1

Differential effects of the second dose of SARS-CoV-2 mRNA vaccine on T cell immunity in previously untreated and COVID-19 recovered individuals https://www.biorxiv.org/content/10.1101/2021.03.22.436441v1

Op-Ed: Stop ignoring natural immunity to COVID https://www.medpagetoday.com/infectiousdisease/covid19/92836?xid=nl_secondopinion_2021-06-01&eun=g1666187d0r

Association of SARS-CoV-2 seropositive antibody testing with risk of future infection https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2776810

SARS-CoV-2 seropositivity and risk of subsequent infection in healthy young adults: a prospective cohort study https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00158-2/fulltext

Associations of vaccination and prior infection with positive PCR test results for SARS-CoV-2 in airline passengers arriving in Qatar https://jamanetwork.com/journals/jama/article-abstract/2781112

Natural immunity against COVID-19 significantly reduces the risk of reinfection: findings from a cohort of serosurvey participants https://www.medrxiv.org/content/10.1101/2021.07.19.21260302v1

Durable immunity found after recovery from COVID-19 https://www.nih.gov/news-events/nih-research-matters/lasting-immunity-found-after-recovery-covid-19#main-content

SARS-CoV-2 natural antibody response persists for at least 12 months in a nationwide Faroese study https://academic.oup.com/ofid/article/8/8/ofab378/6322055

SARS-CoV-2-specific T-cell memory is maintained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells https://www.nature.com/articles/s41467-021-24377-1?utm_source=other&utm_medium=other&utm_content=null&utm_campaign=JRCN_1_LW01_CN_natureOA_article_paid_XMOL

Immunological memory in patients with mild COVID-19 and unexposed donors reveals persistent T-cell responses after SARS-CoV-2 infection https://pubmed.ncbi.nlm.nih.gov/33777028/

Natural COVID-19 immunity https://apps.who.int/iris/bitstream/handle/10665/341241/WHO-2019-nCoV-Sci-Brief-Natural-immunity-2021.1-eng.pdf?sequence=3&isAllowed=y

Antibody evolution after vaccination with SARS-CoV-2 mRNA https://www.biorxiv.org/content/10.1101/2021.07.29.454333v1

Humoral immune response to SARS-CoV-2 in Iceland https://www.nejm.org/doi/full/10.1056/NEJMoa2026116 

Immunological memory for SARS-CoV-2 assessed up to 8 months post infection https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919858/

The prevalence of adaptive immunity to COVID-19 and reinfection after recovery: a comprehensive systematic review and meta-analysis of https://www.medrxiv.org/content/10.1101/2021.09.03.21263103v3

Reinfection rates among patients who previously tested positive for COVID-19: a retrospective cohort study https://pubmed.ncbi.nlm.nih.gov/33718968/

Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2780557

JANUARY 8TH UPDATE: Here’s an infamous study from Denmark that shows how the vaccinated are more likely to get “covid” and how their inmune system MAY have already been compromised. God fucking damnit, can we stop pretending that the NON-vaccinated are the problem or are we that delusional???

https://www.medrxiv.org/content/10.1101/2021.12.20.21267966v3

https://www.medrxiv.org/content/10.1101/2021.12.20.21267966v3.full.pdf




Source: https://elcolectivodeuno.wordpress.com/2021/12/29/how-much-more-evidence-do-you-need-here-is-a-list-of-860-scientific-studies-and-reports-linking-covid-vaccines-to-hundreds-of-adverse-effects-and-deaths/